MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Making the Connections: My Nurse's Proactive Approach to Treatment

February 17th 2016, 2:34am

Article

An essay honoring Emily A. Knight, RN, OCN [Mayo Clinic Cancer Center in Scottsdale, Arizona.

Rebecca N. Claassen on the Importance of Educating Nurses About MPNs

December 21st 2015, 4:01pm

Video

Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).

Susan Melvin Hill on Supporting MPN Patients in Idaho

December 21st 2015, 3:59pm

Video

Susan Melvin Hill, patient advocate, discusses how she meets with and helps patients with myeloproliferative neoplasms (MPNs) in Idaho.

Personalizing Treatment From Start to Finish in Polycythemia Vera

November 11th 2015, 8:36pm

Article

Ruben A. Mesa addressed the current treatment landscape for PV last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals.

Supportive Care Can Impact Long-Term Outcomes in MDS

November 11th 2015, 7:44pm

Article

CURE interviewed Thomas Prebet to gain insight into the importance of supportive care in myelodysplastic syndrome.

Aziz Nazha on Adverse Events Associated With Treatment for MDS

October 1st 2015, 1:50am

Article

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Aziz Nazha Discusses the Future of Treating Patients With MDS

October 1st 2015, 1:43am

Article

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Treatment of Patients With MDS Built Upon Foundation of Supportive Care

May 7th 2015, 8:22pm

Article

Treatment strategies for patients with MDS are built upon a foundation of supportive care, which consists of transfusions, iron chelation, and growth factor therapy.

FDA Approves Jadenu, a Simpler Formulation for Administering Deferasirox

March 31st 2015, 7:15pm

Article

The Food and Drug Administration (FDA) has approved Jadenu (deferasirox) for the treatment of chronic iron overload, a condition that can affect patients with myelodysplastic syndromes (MDS), sickle cell disease and thalassemia.

Oncologist Lewis Silverman on Revlimid for Patients with Myelodysplastic Syndrome

January 24th 2015, 1:53am

Article

Lewis Silverman, an oncologist with Mount Sinai Medical Center, discusses a clinical trial involving Revlimid (lenalidomide) for patients with a type of myelodysplastic syndrome.